BRIEF-GenMark Diagnostics reports Q2 loss per share of $0.30
July 28, 2016 at 16:54 PM EDT
* For full year 2016, company continues to expect gross margin expectations have increased to 57% to 59%
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.